Longitude Capital Partners III, LLC Insider Trading $MTEM Molecular Templates, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Longitude Capital Partners III, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Longitude Capital Partners III, LLC. Longitude Capital Partners III, LLC is 10% Owner in Molecular Templates, Inc. ($MTEM) and 10% Owner in Sierra Oncology, Inc. ($SRRA) and 10% Owner in Axonics Modulation Technologies, Inc. ($AXNX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in 89bio, Inc. ($ETNB) and 10% Owner in Talaris Therapeutics, Inc. ($TALS).
Longitude Capital Partners III, LLC in Molecular Templates, Inc.
Trading Symbol: MTEMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners III, LLC: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 01 2020
$MTEM Market Capitalization: $41.30M
$MTEM Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Longitude Capital Partners III, LLC in Molecular Templates, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, AXNX, INZY, MTEM, SRRA, TALS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 01 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Sell | S | 10.75 | 1,049 | 11,273 | 0 | 1 K to 0 (-100.00 %) |
Sep 01 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Sell | S | 10.75 | 2,447 | 26,296 | 0 | 2.4 K to 0 (-100.00 %) |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | J | 0.00 | 1,049 | 0 | 1,049 | 0 to 1 K |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | J | 0.00 | 2,447 | 0 | 2,447 | 0 to 2.4 K |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | J | 0.00 | 3,495 | 0 | 3,495 | 0 to 3.5 K |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 3,199,035 | 4.2 M to 3.2 M (-23.81 %) |
Nov 27 2019 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 8.00 | 937,000 | 7,496,000 | 4,198,535 | 3.3 M to 4.2 M (+28.73 %) |
Sep 25 2018 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 5.50 | 365,000 | 2,007,500 | 3,261,535 | 2.9 M to 3.3 M (+12.60 %) |
Sep 25 2018 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 5.50 | 365,000 | 2,007,500 | 3,261,535 | 2.9 M to 3.3 M (+12.60 %) |
Page: 1